Patent · US Expired

Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors

US7790399B2 · kind B2 · utility

1Cited by
2References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 5, 2004
Grant dateSep 7, 2010
Priority date
Expiry dateDec 17, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/732
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method for the production and the selection of human or chimæric or humanized antibodies or molecules that comprise the Fc region of human IgG, capable of modulating the activity of one or several particular Fc receptors, such as the triggering of inhibitory functions through the human type IIB receptors of IgG (FcgammaRIIB/CD32).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.